{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T23:31:20Z","timestamp":1767915080336,"version":"3.49.0"},"reference-count":45,"publisher":"Oxford University Press (OUP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Public Health"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1093\/eurpub\/ckv227","type":"journal-article","created":{"date-parts":[[2016,5,28]],"date-time":"2016-05-28T08:52:30Z","timestamp":1464425550000},"page":"498-505","source":"Crossref","is-referenced-by-count":6,"title":["Clinical effectiveness of cancer screening biomarker tests offered as self-pay health service: a systematic review"],"prefix":"10.1093","volume":"26","author":[{"given":"Agnes","family":"Luzak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petra","family":"Schnell-Inderst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefanie","family":"B\u00fchn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anja","family":"Mayer-Zitarosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uwe","family":"Siebert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2016,1,4]]},"reference":[{"key":"2016061707222313000_26.3.498.1","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s10198-005-0312-3","article-title":"Defining the \u201cHealth Benefit Basket\u201d in nine European countries. Evidence from the European Union Health BASKET Project","volume":"6","author":"Schreyogg","year":"2005","journal-title":"Eur J Health Econ"},{"key":"2016061707222313000_26.3.498.2","doi-asserted-by":"publisher","DOI":"10.1017\/S0266462309990092"},{"key":"2016061707222313000_26.3.498.3","doi-asserted-by":"publisher","DOI":"10.1007\/s00038-013-0494-x"},{"key":"2016061707222313000_26.3.498.4","first-page":"234","article-title":"Individuelle Gesundheitsleistungen","volume":"113","author":"Schnell-Inderst","year":"2011","journal-title":"Individuelle Gesundheitsleistungen. Schriftenreihe Health Technology Assessment"},{"key":"2016061707222313000_26.3.498.5","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-156-3-201202070-00006"},{"key":"2016061707222313000_26.3.498.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.zefq.2011.03.004"},{"key":"2016061707222313000_26.3.498.7","unstructured":"Wilson J Jungner G . Principles and practice of screening for disease. Public Health Paper Number 34. Geneva: WHO, 1968."},{"key":"2016061707222313000_26.3.498.8","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.06.107"},{"key":"2016061707222313000_26.3.498.9","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.b2587"},{"key":"2016061707222313000_26.3.498.10","first-page":"385","article-title":"Screening\u2014part 19 of a series on evaluation of scientific publications","volume":"109","author":"Spix","year":"2012","journal-title":"Dtsch Arztebl Int"},{"key":"2016061707222313000_26.3.498.11","unstructured":"UK National Screening Committee. Criteria for appraising the viability, effectiveness and appropriateness of a screening programmes. Available at: https:\/\/www.gov.uk\/government\/publications\/evidence-review-criteria-national-screening-programmes (16 October 2015, date last accessed)."},{"key":"2016061707222313000_26.3.498.12","unstructured":"Gemeinsamen Bundesausschuss. Richtlinie \u00fcber die Fr\u00fcherkennung von Krebserkrankungen 2009. Available at: https:\/\/www.g-ba.de\/downloads\/62-492-950\/KFE-RL_2014-07-24.pdf (16 October 2015, date last accessed.)"},{"key":"2016061707222313000_26.3.498.13","unstructured":"Bundesministerium f\u00fcr Gesundheit. Nationaler Krebsplan. Handlungsfeld 1: Weiterentwicklung der Krebsfr\u00fcherkennung. Ziel 3: Evaluation Krebsfr\u00fcherkennung. 2010. Available at: http:\/\/www.bmg.bund.de\/fileadmin\/dateien\/Downloads\/N\/Nationaler_Krebsplan\/Ziel_3_Evaluation_der_Krebsfrueherkennung.pdf (18 June 2012, date last accessed)."},{"key":"2016061707222313000_26.3.498.14","first-page":"39","article-title":"Die AWMF: Mehr als nur Koordination von Leitlinien","volume":"138","author":"H\u00fcgler","year":"2013","journal-title":"Dtsch Med Wochenschr"},{"key":"2016061707222313000_26.3.498.15","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.c4543"},{"key":"2016061707222313000_26.3.498.16","doi-asserted-by":"publisher","DOI":"10.1054\/bjoc.2000.1375"},{"key":"2016061707222313000_26.3.498.17","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-7-10"},{"key":"2016061707222313000_26.3.498.18","unstructured":"National Institute for Health and Clinical Excellence. The guidelines manual. 2009. Available at: http:\/\/www.nice.org.uk\/aboutnice\/howwework\/developingniceclinicalguidelines\/clinicalguidelinedevelopmentmethods\/GuidelinesManual2009.jsp (2 July 2012, date last accessed)."},{"key":"2016061707222313000_26.3.498.19","first-page":"i","article-title":"Screening for ovarian cancer: a systematic review","volume":"2","author":"Bell","year":"1998","journal-title":"Health Technol Assess (Winch Eng)"},{"key":"2016061707222313000_26.3.498.20","unstructured":"Myers E Havrilesky L Kulasingam S , . Genomic tests for ovarian cancer detection and management. Evid Rep Technol Assess. No. 145. AHRQ Publication. 2006. No. 07-E001."},{"key":"2016061707222313000_26.3.498.21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2013.06.029"},{"key":"2016061707222313000_26.3.498.22","unstructured":"Nelson H Westhoff C Piepert J Berg A . Screening for Ovarian Cancer: Brief Evidence Update. Rockville, MD: AHRQ, 2004."},{"key":"2016061707222313000_26.3.498.23","unstructured":"Barton M Lin K . Screening for Ovarian Cancer: Evidence Update for the U.S. Preventive Services Task Force Reaffirmation Recommendation Statement. AHRQ Publication No. 12-05165-EF3. Rockville, MD: AHRQ, 2012."},{"key":"2016061707222313000_26.3.498.24","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-153-7-201010050-00009"},{"key":"2016061707222313000_26.3.498.25","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2011.766"},{"key":"2016061707222313000_26.3.498.26","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(09)70026-9"},{"key":"2016061707222313000_26.3.498.27","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0b013e31819cda77"},{"key":"2016061707222313000_26.3.498.28","unstructured":"Leitlinienprogramm Onkologie (Deutsche Krebsgesellschaft, Deutsche Krebshilfe, AWMF): S3-Leitlinie Diagnostik, Therapie und Nachsorge maligner Ovarialtumoren, Langversion 1.1, 2013, AWMF-Registernummer: 032\/035OL. http:\/\/leitlinienprogramm-onkologie.de\/Leitlinien.7.0.html."},{"key":"2016061707222313000_26.3.498.29","unstructured":"Leitlinienprogramm Onkologie (Deutsche Krebsgesellschaft, Deutsche Krebshilfe, AWMF): Interdisziplin\u00e4re Leitlinie der Qualit\u00e4t S3 zur Frherkennung, Diagnose und Therapie der verschiedenen Stadien des Prostatakarzinoms, Langversion 3.1, 2014 AWMF-Registernummer: 034\/022OL. http:\/\/leitlinienprogramm-onkologie.de\/Leitlinien.7.0.html."},{"key":"2016061707222313000_26.3.498.30","unstructured":"Leitlinienprogramm Onkologie (Deutsche Krebsgesellschaft, Deutsche Krebshilfe, AWMF): S3-Leitlinie Kolorektales Karzinom, Langversion 1.1, 2014, AWMF Registrierungsnummer: 021-007OL. http:\/\/leitlinienprogramm-onkologie.de\/Leitlinien.7.0.html."},{"key":"2016061707222313000_26.3.498.31","unstructured":"Leitlinienprogramm Onkologie (Deutsche Krebsgesellschaft, Deutsche Krebshilfe, AWMF): Diagnostik und Therapie des hepatozellul\u00e4ren Karzinoms, Langversion 1.0, AWMF Registrierungsnummer: 032-053OL. http:\/\/leitlinienprogramm-onkologie.de\/Leitlinien.7.0.html."},{"key":"2016061707222313000_26.3.498.32","unstructured":"Leitlinienprogramm Onkologie (Deutsche Krebsgesellschaft, Deutsche Krebshilfe, AWMF): S3-Leitlinie Exokrines Pankreaskarzinom, Langversion 1.0, 2013, AWMF Registernummer: 032-010OL. http:\/\/leitlinienprogramm-onkologie.de\/Leitlinien.7.0.html."},{"key":"2016061707222313000_26.3.498.33","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.27909"},{"key":"2016061707222313000_26.3.498.34","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2013.11.030"},{"key":"2016061707222313000_26.3.498.35","doi-asserted-by":"publisher","DOI":"10.1055\/s-0029-1243837"},{"key":"2016061707222313000_26.3.498.36","unstructured":"Leitlinienprogramm Onkologie (Deutsche Krebsgesellschaft, Deutsche Krebshilfe, AWMF):Interdisziplin\u00e4re S3-Leitlinie f\u00fcr die Diagnostik, Therapie und Nachsorge des Mammakarzinoms Langversion 3.0, Update 2012. AWMF Registrierungsnummer: 032-045OL. http:\/\/leitlinienprogramm-onkologie.de\/Leitlinien.7.0.html."},{"key":"2016061707222313000_26.3.498.37","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.14.2364"},{"key":"2016061707222313000_26.3.498.38","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.08.2644"},{"key":"2016061707222313000_26.3.498.39","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2010.06.039"},{"key":"2016061707222313000_26.3.498.40","doi-asserted-by":"crossref","unstructured":"Wun YT Dickinson JA . Alpha-fetoprotein and\/or liver ultrasonography for liver cancer screening in patients with chronic hepatitis B. Cochr Datab Syst Rev 2003; CD002799.","DOI":"10.1002\/14651858.CD002799"},{"key":"2016061707222313000_26.3.498.41","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2013.177"},{"key":"2016061707222313000_26.3.498.42","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp1401875"},{"key":"2016061707222313000_26.3.498.43","doi-asserted-by":"publisher","DOI":"10.1016\/j.pec.2009.10.029"},{"key":"2016061707222313000_26.3.498.44","unstructured":"IGeL-Monitor. NMP22-Test zur Fr\u00fcherkennung von Harnblasenkrebs. Available at: http:\/\/www.igel-monitor.de\/IGeL_A_Z.php?action=abstract&id=83 (16 November 2014, date last accessed)."},{"key":"2016061707222313000_26.3.498.45","unstructured":"IGeL-Monitor. M2-PK Stuhltest zur Darmkrebsfr\u00fcherkennung. Available at: http:\/\/www.igel-monitor.de\/IGeL_A_Z.php?action=abstract&id=77 (16 November 2014, date last accessed)."}],"container-title":["The European Journal of Public Health"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/eurpub\/article-pdf\/26\/3\/498\/7471806\/ckv227.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,9]],"date-time":"2019-09-09T00:46:24Z","timestamp":1567989984000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurpub\/article-lookup\/doi\/10.1093\/eurpub\/ckv227"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,4]]},"references-count":45,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2016,5,28]]},"published-print":{"date-parts":[[2016,6]]}},"alternative-id":["10.1093\/eurpub\/ckv227"],"URL":"https:\/\/doi.org\/10.1093\/eurpub\/ckv227","relation":{},"ISSN":["1101-1262","1464-360X"],"issn-type":[{"value":"1101-1262","type":"print"},{"value":"1464-360X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,4]]}}}